Global Pulmonary Arterial Hypertension Market Size & Outlook
The pulmonary arterial hypertension industry worldwide is expected to reach a projected revenue of US$ 10,609.4 million by 2030. A compound annual growth rate of 5.3% is expected of the worldwide pulmonary arterial hypertension industry from 2024 to 2030.
Revenue, 2023 (US$M)
$7,377.6
Forecast, 2030 (US$M)
$10,609.4
CAGR, 2024 - 2030
5.3%
Report Coverage
Worldwide
Global pulmonary arterial hypertension market, 2018-2030 (US$M)
Related Markets
Global pulmonary arterial hypertension market highlights
- The global pulmonary arterial hypertension market generated a revenue of USD 7,377.6 million in 2023 and is expected to reach USD 10,609.4 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 5.3% by 2030.
- In terms of segment, prostacyclin and prostacyclin analogs accounted for a revenue of USD 3,487.0 million in 2023.
- SGC Stimulators is the most lucrative drug class segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Denmark is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 7,377.6 million |
| Market revenue in 2030 | USD 10,609.4 million |
| Growth rate | 5.3% (CAGR from 2023 to 2030) |
| Largest segment | Prostacyclin and prostacyclin analogs |
| Fastest growing segment | SGC Stimulators |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, SGC Stimulators |
Other key industry trends
- In terms of revenue, the North America accounted for 43.7% of the global pulmonary arterial hypertension market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Denmark is the fastest growing regional market and is projected to reach USD 78.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pulmonary Arterial Hypertension Market Scope
Pulmonary arterial hypertension market segmentation & scope
Endothelin Receptor Antagonists (ERAs)
PDE-5 Inhibitors
Prostacyclin and Prostacyclin Analogs
SGC Stimulators
Pulmonary Arterial Hypertension Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global pulmonary arterial hypertension market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pulmonary arterial hypertension market will help companies and investors design strategic landscapes.
prostacyclin and prostacyclin analogs was the largest segment with a revenue share of 47.26% in 2023. Horizon Databook has segmented the Global pulmonary arterial hypertension market based on endothelin receptor antagonists (eras), pde-5 inhibitors, prostacyclin and prostacyclin analogs, sgc stimulators covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Pulmonary Arterial Hypertension Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Endothelin Receptor Antagonists (ERAs)
- PDE-5 Inhibitors
- Prostacyclin and Prostacyclin Analogs
- SGC Stimulators
- Global Pulmonary Arterial Hypertension Type Outlook (Revenue, USD Million, 2018-2030)
- Branded
- Generics
- Global Pulmonary Arterial Hypertension Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Oral
- Intravenous/ subcutaneous
- Inhalational
Reasons to subscribe to Global pulmonary arterial hypertension market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global pulmonary arterial hypertension market databook
-
Our clientele includes a mix of pulmonary arterial hypertension market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global pulmonary arterial hypertension market , including forecasts for subscribers. This global databook contains high-level insights into Global pulmonary arterial hypertension market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global pulmonary arterial hypertension market statistics, by region, 2018-2030 (US$M)
Top 10 countries: Pulmonary arterial hypertension market size, 2023 (USD Million)
Top 10 countries: Pulmonary arterial hypertension market size, 2023 (USD Million)
Global pulmonary arterial hypertension market, by region, 2023 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
